SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950157-15-000423
Filing Date
2015-04-29
Accepted
2015-04-29 10:04:54
Documents
5
Period of Report
2015-04-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT form_8k.htm 8-K 35717
2 AGREEMENT ex10_1.htm EX-10.1 184479
3 RETIREMENT LETTER AGREEMENT ex10_2.htm EX-10.2 165887
4 PRESS RELEASE OF ARIAD ex99_1.htm EX-99.1 13142
5 PRESS RELEASE OF ARIAD ex99_2.htm EX-99.2 43077
  Complete submission text file 0000950157-15-000423.txt   443564
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36172 | Film No.: 15810444
SIC: 2836 Biological Products, (No Diagnostic Substances)